These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 19505953)
21. MiR-144 affects fatty acid composition by regulating ELOVL6 expression in duck hepatocytes. He J; Tian Y; Zhao Y; Liu Y; Tao Z; Li G; Niu D; Lu L; Lu Y Cell Biol Int; 2017 Jun; 41(6):691-696. PubMed ID: 28225172 [TBL] [Abstract][Full Text] [Related]
22. Piperazine oxadiazole inhibitors of acetyl-CoA carboxylase. Bourbeau MP; Siegmund A; Allen JG; Shu H; Fotsch C; Bartberger MD; Kim KW; Komorowski R; Graham M; Busby J; Wang M; Meyer J; Xu Y; Salyers K; Fielden M; Véniant MM; Gu W J Med Chem; 2013 Dec; 56(24):10132-41. PubMed ID: 24294923 [TBL] [Abstract][Full Text] [Related]
23. Identification of novel inhibitors of the streptogramin group A acetyltransferase via virtual screening. Wang GF; Huang N; Meng ZH; Liu QH Yao Xue Xue Bao; 2007 Jan; 42(1):47-53. PubMed ID: 17520806 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors. Wang X; Sarris K; Kage K; Zhang D; Brown SP; Kolasa T; Surowy C; El Kouhen OF; Muchmore SW; Brioni JD; Stewart AO J Med Chem; 2009 Jan; 52(1):170-80. PubMed ID: 19072118 [TBL] [Abstract][Full Text] [Related]
25. Elovl6: a new player in fatty acid metabolism and insulin sensitivity. Matsuzaka T; Shimano H J Mol Med (Berl); 2009 Apr; 87(4):379-84. PubMed ID: 19259639 [TBL] [Abstract][Full Text] [Related]
26. [Role of Fatty Acid Elongase Elovl6 in the Regulation of Fatty Acid Quality and Lifestyle-related Diseases]. Matsuzaka T; Shimano H Yakugaku Zasshi; 2022; 142(5):473-476. PubMed ID: 35491151 [TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors. Onda K; Shiraki R; Ogiyama T; Yokoyama K; Momose K; Katayama N; Orita M; Yamaguchi T; Furutani M; Hamada N; Takeuchi M; Okada M; Ohta M; Tsukamoto S Bioorg Med Chem; 2008 Dec; 16(23):10001-12. PubMed ID: 18952447 [TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of elongase of very long-chain fatty acids 6 (elovl6) genes in Misgurnus anguillicaudatus and their potential roles in adaptation to cold temperature. Chen J; Cui Y; Yan J; Jiang J; Cao X; Gao J Gene; 2018 Aug; 666():134-144. PubMed ID: 29733968 [TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of potent and selective azaindole-based Rho kinase (ROCK) inhibitors. Schirok H; Kast R; Figueroa-Pérez S; Bennabi S; Gnoth MJ; Feurer A; Heckroth H; Thutewohl M; Paulsen H; Knorr A; Hütter J; Lobell M; Münter K; Geiss V; Ehmke H; Lang D; Radtke M; Mittendorf J; Stasch JP ChemMedChem; 2008 Dec; 3(12):1893-904. PubMed ID: 18973168 [TBL] [Abstract][Full Text] [Related]
30. Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries. Schuster D; Nashev LG; Kirchmair J; Laggner C; Wolber G; Langer T; Odermatt A J Med Chem; 2008 Jul; 51(14):4188-99. PubMed ID: 18533708 [TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and biological activity of new CDK4-specific inhibitors, based on fascaplysin. Aubry C; Wilson AJ; Jenkins PR; Mahale S; Chaudhuri B; Maréchal JD; Sutcliffe MJ Org Biomol Chem; 2006 Mar; 4(5):787-801. PubMed ID: 16493461 [TBL] [Abstract][Full Text] [Related]
32. Separate entrance and exit portals for ligand traffic in Mycobacterium tuberculosis FabH. Sachdeva S; Musayev FN; Alhamadsheh MM; Scarsdale JN; Wright HT; Reynolds KA Chem Biol; 2008 Apr; 15(4):402-12. PubMed ID: 18420147 [TBL] [Abstract][Full Text] [Related]
33. Oct-2-en-4-ynoyl-CoA as a specific inhibitor of acyl-CoA oxidase. Zeng J; Wu L; Zhang X; Liu Y; Deng G; Li D Org Lett; 2008 Oct; 10(19):4287-90. PubMed ID: 18754593 [TBL] [Abstract][Full Text] [Related]
35. Crucial Role of Elovl6 in Chondrocyte Growth and Differentiation during Growth Plate Development in Mice. Kikuchi M; Shimada M; Matsuzaka T; Ishii K; Nakagawa Y; Takayanagi M; Yamada N; Shimano H PLoS One; 2016; 11(7):e0159375. PubMed ID: 27467521 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of dynamin mediated endocytosis by the dynoles--synthesis and functional activity of a family of indoles. Hill TA; Gordon CP; McGeachie AB; Venn-Brown B; Odell LR; Chau N; Quan A; Mariana A; Sakoff JA; Chircop M; Robinson PJ; McCluskey A J Med Chem; 2009 Jun; 52(12):3762-73. PubMed ID: 19459681 [TBL] [Abstract][Full Text] [Related]
38. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism. Tamura K; Makino A; Hullin-Matsuda F; Kobayashi T; Furihata M; Chung S; Ashida S; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H Cancer Res; 2009 Oct; 69(20):8133-40. PubMed ID: 19826053 [TBL] [Abstract][Full Text] [Related]
39. The effect of PLC-γ2 inhibitors on the growth of human tumour cells. Feng L; Reynisdóttir I; Reynisson J Eur J Med Chem; 2012 Aug; 54():463-9. PubMed ID: 22698703 [TBL] [Abstract][Full Text] [Related]
40. Micro method for determination of nonesterified fatty acid in whole blood obtained by fingertip puncture. Hansen JS; Villadsen JK; Gaster M; Faergeman NJ; Knudsen J Anal Biochem; 2006 Aug; 355(1):29-38. PubMed ID: 16814738 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]